Trinity Biotech Enters Into $81M Loan Facility To Refinance Existing Debt
See more from Benzinga
Valneva's COVID-19 Vaccine Booster Works As A Follow-Up To Its Own Shot
FDA Lab Testing Confirms SAB Biotherapeutics' COVID-19 Antibody Neutralizes Omicron Variant
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.